Alcohol Dependence Clinical Trial
Official title:
Mechanisms Underlying the Approach and Avoidance Task (AAT) in Alcoholic Inpatients
The approach and avoidance task (AAT) has evolved as a promising treatment add-on in the
realm of psychology. Certain psychiatric diseases, such as behavioural addictions, social
anxiety disorder, and arachnophobia, are characterized by a dysfunctional tendency to either
approach or avoid disease-specific objects. This tendency can be measured by means of the
approach and avoidance task. In this so-called diagnostic AAT participants are instructed to
react upon the format or the frame colour of a picture. For instance, pictures have to be
pushed away if they are presented in landscape format and pulled towards oneself if they are
presented in portrait format (or vice versa). Hence, the format (or the frame colour) becomes
the task-relevant dimension, whereas the content of the picture becomes the task-irrelevant
dimension. However, what generally becomes obvious in the psychiatric diseases mentioned
above is that the task-irrelevant dimension (picture content) exerts an influence on reaction
times. For instance, alcoholic patients are generally faster to respond if alcoholic pictures
are presented in a format requiring them to pull towards themselves and slower to respond if
alcoholic pictures are shown in the format requiring them to push away a joystick. This
behavioural tendency has been termed an approach bias for alcohol.
In order to counteract these dysfunctional approach or avoidance tendencies, an AAT-training
has been developed. In this training participants/patients learn to either avoid or approach
disease-specific objects. Alcohol-dependent patients, for instance, learn to avoid
alcohol-related pictures by pushing or swiping the image away. It has been shown that these
trainings can enhance treatment outcome (e.g. lower relapse rates) among alcohol-addicted
patients (Wiers, Eberl, Rinck, Becker, & Lindenmeyer, 2011). The aim of the current study is
to test whether the avoidance gesture is as important as suggested by the AAT's name or
whether inhibiting the urge to approach alcoholic content might be enough to bring about the
effect.
Status | Recruiting |
Enrollment | 90 |
Est. completion date | August 31, 2020 |
Est. primary completion date | August 31, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Diagnosis of alcohol dependence (SKID-I) - Abstinence from alcohol (at least 72 hours) and absence of major withdrawal symptoms - Being in between 18-76 years of age - Being able to understand rationales of the study and signing written informed consent - Currently being inpatient seeking help overcoming alcohol dependence - Medication allowed: Antiepileptic's (such as Carbamezepin), antidepressants, substances to treat other non-psychiatric diseases Exclusion Criteria: - Impaired ability to cooperate - Presence of another substance dependency than alcohol and nicotine within the last year - Presence of another axis-I disorder that interferes with the ability to cooperate within the study programme - Current episode of a major depression - Presence of axis-II disorders - Presence of schizoaffective disorders - Alcohol consumption in between withdrawal and start of the study - Somatic or neurological disease that precludes the proper execution of the study - Long-term intake of neuroleptics or hypnotics - Current intake of benzodiazepines or Clomethiazol (in the period of five half-value times prior to the start of the study) - Participation in other studies or other treatments than treatment as usual - Planned long-term therapy after 3-week withdrawal programme - Being homeless - Prior electroconvulsive therapy - Language barriers that preclude proper understanding of study contents |
Country | Name | City | State |
---|---|---|---|
Germany | University Clinic Hamburg-Eppendorf | Hamburg |
Lead Sponsor | Collaborator |
---|---|
Universitätsklinikum Hamburg-Eppendorf |
Germany,
Eberl C, Wiers RW, Pawelczack S, Rinck M, Becker ES, Lindenmeyer J. Approach bias modification in alcohol dependence: do clinical effects replicate and for whom does it work best? Dev Cogn Neurosci. 2013 Apr;4:38-51. doi: 10.1016/j.dcn.2012.11.002. Epub 2 — View Citation
Kühn S, Lorenz RC, Weichenberger M, Becker M, Haesner M, O'Sullivan J, Steinert A, Steinhagen-Thiessen E, Brandhorst S, Bremer T, Gallinat J. Taking control! Structural and behavioural plasticity in response to game-based inhibition training in older adul — View Citation
Smith JL, Mattick RP, Jamadar SD, Iredale JM. Deficits in behavioural inhibition in substance abuse and addiction: a meta-analysis. Drug Alcohol Depend. 2014 Dec 1;145:1-33. doi: 10.1016/j.drugalcdep.2014.08.009. Epub 2014 Aug 24. Review. — View Citation
Wiers RW, Eberl C, Rinck M, Becker ES, Lindenmeyer J. Retraining automatic action tendencies changes alcoholic patients' approach bias for alcohol and improves treatment outcome. Psychol Sci. 2011 Apr;22(4):490-7. doi: 10.1177/0956797611400615. Epub 2011 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Alcohol consumption | Is measured by means of the timeline followback (TLFB). In the TLFB a thirty day period prior to hospitalization is inquired to get an impression of the alcohol consumption before detoxification. Both after the intervention period and at the follow-up measure 9 weeks after the end of the intervention period the TLFB is administered to the participants again. Thus, in total a period of 3 months after the enrollment in the study is captured by means of the TLFB and can be compared between groups and with baseline consumption of each individual. | 3 months | |
Primary | Relapse rate | At each point of measurement it is inquired whether participants had a relapse. In order to enrich these self-reports, breathalysers are used to screen for possible alcohol intake prior to the appointment. | 3 months | |
Secondary | Diagnostic AAT | In order to look whether participants' approach bias for alcohol changes as a consequence of the intervention, the diagnostic AAT is administered to all participants at every point of measurement. | 3 months | |
Secondary | Obsessive Compulsive Drinking Scale | A measure of aclohol addiction severity and craving. | 3 months | |
Secondary | Alcohol Urge Questionnaire | Assesses the urge to consume alcohol. | 3 months | |
Secondary | The State Trait Anxiety Inventory (STAI) | Is a commonly used measure of state and trait anxiety. Trait anxiety is assessed at the baseline measure, whereas potential changes in state anxiety are monitored across all three points of measurement of the study. | 3 months | |
Secondary | Positive and Negative Affect Schedule | Is a self-report questionnaire that consists of two 10-item scales to measure both positive and negative affect. | 3 months | |
Secondary | Self-Control Scale | The self-control scale aims to assess people's ability to control their impulses, alter their emotions and thoughts, and to interrupt undesired behavioural tendencies and refrain from acting on them. | 3 months | |
Secondary | Becks's Depression Inventory | Assesses the degree of depressive symptoms. | 3 months | |
Secondary | Fagerström Test of Nicotine Dependence (FTND) | Fagerstrom test for nicotine addiction determines the degree of nicotine dependence based on smoking habits and frequency. | 3 months | |
Secondary | Barrett Impulsiveness Scale | A questionnaire designed to assess the personality/behavioral construct of impulsiveness. | 3 months | |
Secondary | Behavioral inhibition/avoidance scales | The BIS/BAS Scale is a 24-item self-report questionnaire designed to measure two motivational systems: the behavioral inhibition system (BIS), which corresponds to motivation to avoid aversive outcomes, and the behavioral activation system (BAS), which corresponds to motivation to approach goal-oriented outcomes. | 3 months | |
Secondary | Rating of pictures used in the study | Liking of all alcoholic and non alcoholic stimuli used in the study will be rated on a visual analogue scale, ranging from 0 to 100. | 3 months | |
Secondary | Expectancy Inventory of the intervention | Assesses an individual's expectancies and belief in positive outcomes associated with the training and alcohol treatment in general. | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02901041 -
Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism
|
Phase 3 | |
Completed |
NCT03340051 -
Remote Alcohol Monitoring and Episodic Thinking
|
N/A | |
Not yet recruiting |
NCT06444243 -
Psilocybin-assisted Therapy for Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02705898 -
Lifestyle Physical Activity Intervention for Depressed Alcohol Dependent Women
|
N/A | |
Completed |
NCT02486900 -
Neurofeedback & Alcohol Dependence
|
N/A | |
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02197598 -
Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use
|
Phase 4 | |
Recruiting |
NCT02385643 -
The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients
|
N/A | |
Completed |
NCT01828866 -
Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients
|
N/A | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Active, not recruiting |
NCT01182766 -
New Treatment for Alcohol and Nicotine Dependence
|
Phase 2/Phase 3 | |
Completed |
NCT01342549 -
Treatment Strategy for Alcohol Use Disorders in Veterans With TBI
|
Phase 3 | |
Completed |
NCT02193204 -
Chronic Alcohol, Stress Inflammatory Response and Relapse Risk
|
N/A | |
Completed |
NCT01176591 -
HBPL Study of the Impact of the NK1 Antagonist Aprepitant
|
Phase 2 | |
Completed |
NCT01165541 -
A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency
|
Phase 2 | |
Completed |
NCT00585780 -
Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse
|
Phase 1/Phase 2 | |
Completed |
NCT01056484 -
Mindfulness Meditation for Health
|
Phase 2 | |
Completed |
NCT00607620 -
Disseminating Organizational SBI Services at Trauma Centers
|
N/A | |
Completed |
NCT00884884 -
Aripiprazole and Topiramate on Free-Choice Alcohol Use
|
Phase 2/Phase 3 | |
Completed |
NCT00463346 -
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
|
Phase 3 |